Safety of Aesthetic Medicine Procedures in Patients with Autoimmune Thyroid Disease: A Literature Review

Adamczyk, Kamil; Rusyan, Ewa; Franek, Edward

doi:10.3390/medicina58010030

Cited by 2 publications

(1 citation statement)

References 97 publications

(99 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One of them is the injection of platelet-rich fibrin or plasma. However, it should be remembered that thyroid diseases have a negative effect on the function of platelets, the functioning of which determines the effectiveness of this treatment [33]. Due to the contraindication of the use of PRPs or PRFs in patients with autoimmune diseases, the use of atelocollagen is safer and not associated with the risk of complications.…”

Section: Discussionmentioning

confidence: 99%

Reduction in Gingival Bleeding after Atelocollagen Injection in Patients with Hashimoto’s Disease—A Pilot Study

Klewin-Steinböck

Wyganowska

2023

IJERPH

View full text Add to dashboard Cite

Periodontal diseases are one of the main causes of tooth loss and the second most common oral disease after carries. Patients with autoimmune diseases, such as Hashimoto’s disease, are more often vulnerable to infection. In the study group of patients, despite the lack of other signs of gingivitis, bleeding occurred after tooth brushing or minor trauma. Bleeding on probing is the first objective sign of ongoing inflammation. The study was conducted on a group of 17 patients diagnosed with Hashimoto’s disease. The atelocollagen Linerase (100 mg) thinned with 5 mL 0.9% NaCl was used. A total of 0.05 mL of solution was injected into keratinized gingiva, two millimeters above the gingival papillae basement, four times in two-week intervals. The greatest decrease in the number of bleeding points was observed after the first and second injections of atelocollagen. After the third and fourth injections, the average BOP continued to decrease, but the decline was very slow. The use of atelocollagen made it possible to eliminate bleeding symptoms in the study group.

show abstract

Section: Discussionmentioning

confidence: 99%

Reduction in Gingival Bleeding after Atelocollagen Injection in Patients with Hashimoto’s Disease—A Pilot Study

Klewin-Steinböck

Wyganowska

2023

IJERPH

View full text Add to dashboard Cite

show abstract

Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management

Baranska-Rybak,

Lajo-Plaza,

Walker

et al. 2024

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Hyaluronic acid (HA) dermal fillers, generally considered low-risk, can lead to rare late-onset reactions (LORs) manifesting between 3 and 4 months postinjection, occasionally even as early as 24 h postinjection. The Complication Assessment and Risk Evaluation (CARE) board was established to review these reactions. In this publication, the authors aims to explore the etiological hypotheses underlying LORs, associated risk factors, prevention, and management approaches suggested by the CARE board. The CARE board identified three etiological hypotheses contributing to LORs. Firstly, the physicochemical structure of the filler, particularly low molecular weight HA, which may trigger an immune response. Secondly, infection, potentially introduced during injection or by dormant biofilm activation. Lastly, an imbalance in the host immune system, caused by factors like autoimmune diseases or viral infections, may lead to extended foreign body reactions, delayed type IV hypersensitivity, or adjuvant-based reactions. Based on these hypotheses, the board categorized various risk factors as patient-related (e.g., recent dental treatment, current medical status, active autoimmune disease), product-related (e.g., molecular weight), and procedure-related (e.g., aseptic technique and trauma). To reduce the risk of LORs, the CARE board recommends diligent patient selection, including comprehensive medical history assessment and informed consent. Practitioners should maintain an effective aseptic technique, and choose an appropriate product and injection depth for the anatomical location. Post-procedure, patients should receive education on proper filler care. Management of LORs depends on the suspected etiology, and the CARE board has proposed an algorithm to determine the most appropriate treatment. Hyaluronidase is recommended for noninflammatory reactions in the absence of active infection, while watchful waiting and/or steroid treatment may be preferred for inflammatory reactions. Hyaluronidase is not recommended as a first-line treatment for infections, which require drainage, bacterial culture, and antibiotic treatment. However, the board emphasizes the need for individualized evaluation and treatment in all cases. Supplementary Information The online version contains supplementary material available at 10.1007/s13555-024-01202-3.

show abstract

Safety of Aesthetic Medicine Procedures in Patients with Autoimmune Thyroid Disease: A Literature Review

Cited by 2 publications

References 97 publications

Reduction in Gingival Bleeding after Atelocollagen Injection in Patients with Hashimoto’s Disease—A Pilot Study

Reduction in Gingival Bleeding after Atelocollagen Injection in Patients with Hashimoto’s Disease—A Pilot Study

Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management

Contact Info

Product

Resources

About